Copper Oxodotreotide CU-64

Overview

Copper Oxodotreotide CU-64 is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4297339).

API suppliers (1)

Suppliers of Copper Oxodotreotide CU-64 backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CURIUM US LLCUnited States1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Copper Oxodotreotide CU-64 expires 3 Sept 2041 and exclusivity 3 Sept 2027. Generic API sourcing typically opens up once these lapse.